OpenURL Connection Search

Select item for more details and to access through your institution.

N-dihydrogalactochitosan as a potent immune activator for dendritic cells.
Published in:
Journal of Biomedical Materials Research, Part A, 2017, v. 105, n. 4, p. 963, doi. 10.1002/jbm.a.35991
By:
- El‐Hussein, Ahmed;
- Lam, Samuel S. K.;
- Raker, Joseph;
- Chen, Wei R.;
- Hamblin, Michael R.
Publication type:
Article
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.
Published in:
Nature, 2014, v. 515, n. 7528, p. 577, doi. 10.1038/nature13988
By:
- Gubin, Matthew M.;
- Noguchi, Takuro;
- Ivanova, Yulia;
- Arthur, Cora D.;
- Vesely, Matthew D.;
- Lam, Samuel S. K.;
- Pearce, Erika L.;
- Artyomov, Maxim N.;
- Schreiber, Robert D.;
- Allison, James P.;
- Freeman, Gordon J.;
- Sharpe, Arlene H.;
- Aebersold, Ruedi;
- Melief, Cornelis J. M.;
- Mardis, Elaine R.;
- Zhang, Xiuli;
- Gillanders, William E.;
- Schuster, Heiko;
- Rammensee, Hans-Georg;
- Caron, Etienne
Publication type:
Article
Compensatory dendritic cell development mediated by BATF-IRF interactions.
Published in:
Nature, 2012, v. 490, n. 7421, p. 502, doi. 10.1038/nature11531
By:
- Tussiwand, Roxane;
- Lee, Wan-Ling;
- Murphy, Theresa L.;
- Mashayekhi, Mona;
- KC, Wumesh;
- Albring, Jörn C.;
- Satpathy, Ansuman T.;
- Rotondo, Jeffrey A.;
- Edelson, Brian T.;
- Kretzer, Nicole M.;
- Wu, Xiaodi;
- Weiss, Leslie A.;
- Glasmacher, Elke;
- Li, Peng;
- Liao, Wei;
- Behnke, Michael;
- Lam, Samuel S. K.;
- Aurthur, Cora T.;
- Leonard, Warren J.;
- Singh, Harinder
Publication type:
Article
Novel Immune Stimulant Amplifies Direct Tumoricidal Effect of Cancer Ablation Therapies and Their Systemic Antitumor Immune Efficacy.
Published in:
Cells (2073-4409), 2021, v. 10, n. 3, p. 492, doi. 10.3390/cells10030492
By:
- Korbelik, Mladen;
- Hode, Tomas;
- Lam, Samuel S. K.;
- Chen, Wei R.;
- Mattei, Fabrizio
Publication type:
Article

Found: 4

N-dihydrogalactochitosan as a potent immune activator for dendritic cells.

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.

Compensatory dendritic cell development mediated by BATF-IRF interactions.

Novel Immune Stimulant Amplifies Direct Tumoricidal Effect of Cancer Ablation Therapies and Their Systemic Antitumor Immune Efficacy.